Mingke Pharmaceutical: Eligible for tax incentives through recognition as a high-tech enterprise.

Macy Pharmaceutical announced that the company has been included in the second batch of high-tech enterprise record list for the 2025 Shanghai accreditation institutions, through the accreditation as a high-tech enterprise, certificate number GR202531003769, issued on December 25, 2025, with a validity period of three years. This is a re-accreditation after the expiration of the original certificate, and after accreditation, the company can pay corporate income tax at a rate of 15% for three consecutive fiscal years. This accreditation helps to enhance the core competitiveness of the company, does not affect the current tax incentive policies, and has no significant impact on performance.